(Q41300659)

29 September 2017

1 reference

title

Lipoprotein(a) in health and disease (English)

1 reference

29 September 2017

0 references

Kronenberg F

1

1 reference

29 September 2017

Steinmetz A

series ordinal

2

1 reference

29 September 2017

Kostner GM

series ordinal

3

1 reference

29 September 2017

Dieplinger H

series ordinal

4

1 reference

29 September 2017

publication date

1 January 1996

1 reference

Critical Reviews in Clinical Laboratory Sciences

29 September 2017

published in

1 reference

29 September 2017

volume

33

1 reference

29 September 2017

issue

6

1 reference

29 September 2017

page(s)

495-543

1 reference

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

The recurring evolution of lipoprotein(a). Insights from cloning of hedgehog apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Identification of mutations in human apolipoprotein(a) kringle 4-37 from the study of the DNA of peripheral blood lymphocytes: relevance to the role of lipoprotein(a) in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Turnover of lipoprotein (a) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

The mysteries of lipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

C/T polymorphism in the 5' untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

A potential basis for the thrombotic risks associated with lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Free and Apo B-associated Lpa-specific protein in human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

International Lp(a) standardization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

A prospective study of lipoprotein(a) and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) and ischemic cerebrovascular disease in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Plasma concentration of lipoprotein(a) and the risk of future stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein[a] as a risk factor for preclinical atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (the Québec Cardiovascular Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lp(a) concentrations in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus and borderline hyperglycemia: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Risk factors for cardiovascular disease in IDDM. A study of identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) in subjects with familial defective apolipoprotein B100.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein(a) and acute-phase proteins in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Increased concentrations of serum Lp(a) lipoprotein in patients with primary gout

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Niceritrol reduces plasma lipoprotein(a) levels in patients undergoing maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Effects of tibolone on lipoprotein(a) and HDL subfractions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

Inhibitors for the In Vitro Assembly of Lp(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408369609080056

10.3109/10408369609080056

21 January 2018

Identifiers

DOI

1 reference

release_t3avcyvt4raafckx2shfzfv7lm

29 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t3avcyvt4raafckx2shfzfv7lm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference